Cardio Probiotic from Kaneka earns FDA GRAS status

Kaneka Probiotics (Pasadena, TX) announced Cardio Probiotic (L. plantarum KABP-011, L. plantarum KABP-012, and L. plantarum KABP-013) achieved U.S. FDA GRAS (Generally Recognized as Safe) status.

“The FDA GRAS certification demonstrates our commitment to a higher level of safety and quality for this ingredient,” said Mike Kolifrath, vice president, sales and marketing of the probiotics division at Kaneka, in a press release. “Brands can be assured to have best in class ingredient when selecting to use the Cardio Probiotic raw material blend in their products for lipid metabolism and cardiovascular benefits.”

Cardio Probiotic, based on a foundation of published clinical trials, phenotypic data, and genotypic analysis, is a formulation of three Lactobacillus plantarum strains that specifically supports cholesterol already in normal range.